Biostar Pharmaceuticals, Inc. (BSPM)

[joenatural]

The increase in sales of their Hepatitis B drug (Xin AoXing Oleanolic Acid Capsule: an over-the-counter (“OTC”) drug that treats chronic hepatitis B disease) from $4,857,152 a year ago (3 months sales ended 6-30-08) to $8,943,524 this year (3 months ended 6-30-09) and that doesn't include the rest of the company's drugs ....

"What does the board think was the major reasons behind the sucess of the last quarter?"